AD workbench

Data could hold the key to stopping Alzheimer's

We are delighted to announce that AlbionVC portfolio company Aridhia together with its coalition partners today are launching Alzheimer’s Disease Data Initiative (ADDI) and Alzheimer’s disease (AD) Workbench, a cloud-based platform for scientists to accelerate discoveries and innovations for AD and related dementias. 

The newly formed (AD) Workbench, a cloud-based platform for scientists to accelerate discoveries and innovations for AD and related dementias is a new global effort that aims to advance AD innovation by connecting researchers with the data needed to generate insights and inform the development of improved treatments and diagnostic tools.

Bill Gates notes:

The goal is to simplify how researchers and data scientists around the world work together and share data, code, and knowledge in order to make advances in the field.

Instead of having to navigate dozens of individual databases, scientists will be able to access and upload information to a patient database from around the world. The workbench also facilitates access to datasets from failed drug trials, since many pharmaceutical companies have decided that the benefits of sharing their data outweigh the risks. And all the data is in compliance with privacy laws, so researchers don’t have to worry about compromising anyone’s personal information.

I’m optimistic that this will make a real difference in Alzheimer’s research, because there are many examples where we’ve made progress on diseases after bringing together large amounts of data.

Learn more on why data could hold the key to stopping Alzheimer's on Gates Notes